Worm.com

Company Introduces Cream with Proven Efficacy in Transporting Bio-Active Components beyond the Level of the Skin’s Outer-Most Layer

SCOTTSDALE, Ariz. — eFoodSafety.com, Inc. (OTCBB: EFSF) today announced that its wholly-owned subsidiary Knock-Out Technologies, Ltd. has completed the research and development phase of incorporating its clinically proven product, Citroxin, into a unique trans-dermal cream with proven efficacy in transporting bio-active components beyond the level of the skin’s outer-most layer (stratus corneum).

The goal is to permit the active compounds in Citroxin to enter into systemic circulation, thereby allowing the proven health benefits of Citroxin to quickly improve numerous facets of internal health. On the back of the recent successful lab test demonstrating Citroxin’s ability to eradicate MRSA (Methicillin Resistant Staphylococcus Aureus), the initial aim of Trans-dermal Citroxin will be to allow Citroxin to be delivered in an efficacious dose directly into the bloodstream. This will arm the body’s defense systems to directly deal with most strains of Staph infection.

Robert Bowker, President of Knock-Out Technologies, Ltd., stated, "One of the key challenges in formulating a trans-dermal product was to create a suitable suspension of Citroxin’s components, coupled with the proper vehicle used for trans-dermal delivery. Through continued innovation, we believe we have successfully achieved this objective, resulting in a novel method for introducing Citroxin into the body through a route other than oral ingestion. This achievement is extremely important and beneficial, as many people who are ill or weakened by various factors cannot swallow pills. Additionally, these people, as well as many others, have a deficient ability to properly digest and assimilate nutrients through normal digestive mechanisms. We believe that Trans-dermal Citroxin provides a solution to overcoming these obstacles."

Trans-dermal delivery is a term that relates to any topically applied drug formulations that are meant to deliver one or more active ingredients into the overall circulation. Trans-dermal systems have been formulated to afford controlled delivery of specific drugs into systemic blood supply. These systems can help avoid some typical problems associated with oral ingestion of drugs and nutrients, including destruction of active components from stomach acid, nausea or stomach upset, and reflux from swallowing difficulties. Skin is normally impermeable to most substances. However, certain systems have been designed which allow the skin’s matrix to be permeated with an inactive compound that carries the active ingredient(s) through the normal barrier system. Several drugs are now in use in trans-dermal products, including anti-histamines, beta-blockers, non-steroidal anti-inflammatories, contraceptives, insulin, hormones, and anti-virals.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte[TM] product which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The Company is the owner of Cinnergen[TM], a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism available for sale at (www.cinnergen.com) and through national retailers; and Cinnechol[TM], a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect[TM] anti-acne skin care system.

The company’s iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar[TM], a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body’s immune system. The product contains Citroxin[TM], eFoodSafety’s proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar[TM] is available in three delicious flavors: chocolate, oatmeal-raisin, and orange-apple and can be purchased at www.immuneboost.com.

Information provided by: Findarticles.com

Integrated email and Internet content security
provider Marshal has today launched Sophos for Marshal, the fully
integrated anti-virus and malware detection module for the gateway.
Available immediately as an add-on module to MailMarshal and WebMarshal,
Sophos for Marshal brings together the strengths of market-leading
anti-malware solutions from Sophos and Marshal’s highly acclaimed content
security products to provide even more choice for Marshal customers.

“Sophos for Marshal represents the culmination of an ongoing collaboration
between Marshal and Sophos to deliver a faster and more complete solution,”
said Bradley Anstis, vice president of Products for Marshal. “The new
module provides even more choice to Marshal customers and it broadens our
portfolio to deliver a truly integrated AV and malware module based on a
single engine.”

This version of Sophos for Marshal goes beyond mere malware detection by
providing total protection at the gateway against all known viruses,
spyware, worms and adware, as well as against any potentially unwanted
applications (PUA). Innovative Genotype® and Behavioral® technologies
are made available at the gateway level, better ensuring zero-day
protection against known and unknown threats.

Major improvements have been achieved with the integration of Sophos within
this Marshal solution:

--  The Sophos for Marshal module is now fully integrated with MailMarshal
    SMTP and WebMarshal.
--  Ease of installation: The new Sophos for Marshal module does not
    require any additional software to be installed.
--  This tighter integrated scanner uses a separate updating service for
    increased resilience and deeper integration into the Marshal user
    interfaces, such as the ability to see current scanner status and signature
    version of all installed scanners in the recent WebMarshal 6.0
    administration console.
    

The new integrated module not only offers Marshal customers more choice but
also creates additional revenue potential for security resellers.

Peter Norman, vice president of Product Management and Corporate
Development at Sophos, commented, “This collaboration with Marshal is an
important one. We are confident that Sophos for Marshal will prove to be
effective protection against both virus attacks and potentially unwanted
applications (PUA).”

About Marshal

Marshal is a global leader in Content Security across multiple protocols,
enabling organizations to secure their IT environment, protect against
threats and comply with corporate governance needs. Marshal provides
customers with a complete portfolio of policy-driven Email and Internet
solutions that integrate content filtering, compliance, secure messaging
and archiving. Forty percent of the Global Fortune 500 companies use
Marshal security solutions to secure their corporate messaging networks and
web against internal abuse and external threats such as viruses, spam and
malicious code. More than seven million users in 18,000 companies worldwide
use Marshal solutions to protect their networks, employees, business assets
and corporate reputation and to comply with corporate governance
legislation requirements.

Marshal is headquartered in Atlanta (USA) and London (UK) with further
offices in Paris (France), Munich (Germany), Johannesburg (South Africa),
Houston (USA), Sydney (Australia) and Auckland (New Zealand). More
information is available at www.marshal.com .

About Sophos

Sophos provides solutions that enable enterprises all over the world to
secure and control their IT infrastructure. Sophos’s network access control
and endpoint solutions simplify security to provide an integrated defense
against malware, spyware, intrusions, unwanted applications and policy
abuse. Sophos complements these solutions with innovative email and web
security products that filter traffic for security threats, spam and policy
infringements.

With over 20 years of experience, Sophos’s reliably engineered security
solutions and services protect more than 100 million users in over 140
countries. Recognized for its high level of customer satisfaction and
powerful yet easy-to-use solutions, Sophos has received many industry
awards, as well as positive reviews and certifications. Sophos is
headquartered in Boston, US, and Oxford, UK. More information is available
at www.sophos.com

Media Contact:
Kerri Moran
Carabiner Communications
(770) 452-6424
Email Contact

Information provided by: Findarticles.com